Literature DB >> 26895727

Idiopathic Hypersomnia and Hypersomnolence Disorder: A Systematic Review of the Literature.

Nathaniel A Sowa1.   

Abstract

BACKGROUND: Hypersomnia is a common complaint in medical offices. Often patients are given psychiatric diagnoses, but a primary sleep disorder may be present. The new diagnosis of "hypersomnolence disorder" (HD) in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition is a primary sleep disorder most similar to the diagnosis "idiopathic hypersomnia" (IH) in sleep literature and can be missed in psychiatric settings.
METHODS: A systematic review of the computerized databases PubMed, EMBASE, Web of Science, and Psychinfo using the search criteria "idiopathic AND (hypersomnolence OR hypersomnia)," as well as "hypersomnolence disorder was conducted." Articles were included if they were in English and included information regarding the epidemiology, diagnosis, pathophysiology, or treatment of IH or HD. Where relevant, weighted means and 95% CI were calculated based on the number of subjects in each study.
RESULTS: A total of 143 articles discussed IH, whereas no articles were found regarding HD. Most articles were review articles, prospective studies, or studies of pathophysiology. IH is found in approximately 0.02%-0.010% of the general population, has a mean age of onset of 21.8 years, and is associated with several somatic symptoms. Alterations in histaminergic or dopaminergic signaling may be involved in IH. Treatment with modafinil or other stimulants appears moderately effective. IH can be differentiated from psychiatric hypersomnolence by formal polysomnography.
CONCLUSIONS: IH and HD are relatively uncommon disorders and little is known about them. However, they are distinct from psychiatric disorders and respond well to treatment once properly identified.
Copyright © 2016 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26895727     DOI: 10.1016/j.psym.2015.12.006

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

Authors:  Maeve Pascoe; James Bena; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

2.  Optimizing Actigraphic Estimation of Sleep Duration in Suspected Idiopathic Hypersomnia.

Authors:  Jesse D Cook; Sahand C Eftekari; Lydia A Leavitt; Michael L Prairie; David T Plante
Journal:  J Clin Sleep Med       Date:  2019-04-15       Impact factor: 4.062

3.  Idiopathic Hypersomnia-A Dynamic Simulation Model.

Authors:  Marek Susta; Karel Šonka; Gustav Bizik; Svojmil Petranek; Sona Nevsimalova
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

Review 4.  The Medical and Economic Burden of Narcolepsy: Implications for Managed Care.

Authors:  Michael J Thorpy; George Hiller
Journal:  Am Health Drug Benefits       Date:  2017-07

5.  Idiopathic Hypersomnia Patients Revealed Longer Circadian Period Length in Peripheral Skin Fibroblasts.

Authors:  Linus Materna; Hartmut Halfter; Anna Heidbreder; Matthias Boentert; Julian Lippert; Raphael Koch; Peter Young
Journal:  Front Neurol       Date:  2018-06-07       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.